Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Mouth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006361
What this trial is testing

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT07643870
What this trial is testing

Human ADME Study of [14C]-AZD1390

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 8
Not applicableStudy completedNCT04665973
What this trial is testing

Effect of an Oral Therapeutic Patient Education Session on Physical Activity in Patients With Cancer

Who this might be right for
Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 98
Testing effectiveness (Phase 2)Ended earlyNCT00319683
What this trial is testing

ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Adherex Technologies, Inc.
Large-scale testing (Phase 3)WithdrawnNCT00301886
What this trial is testing

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT05784688
What this trial is testing

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorBiliary Tract CancerHead and Neck Squamous Cell Carcinoma+1 more
TiumBio Co., Ltd. 140
Large-scale testing (Phase 3)UnknownNCT00336947
What this trial is testing

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Yokohama City University 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07116811
What this trial is testing

Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

Who this might be right for
Vestibular SchwannomaFacial Nerve Paralysis
Beijing Tiantan Hospital 364
Not applicableUnknownNCT06256809
What this trial is testing

Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study

Who this might be right for
Oral Leukoplakia
King Khalid University 160
Testing effectiveness (Phase 2)Ended earlyNCT02109016
What this trial is testing

Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations

Who this might be right for
Non-Small Cell Lung CancerSquamous Non-Small Cell Lung CancerNSCLC+6 more
Clovis Oncology, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT00022152
What this trial is testing

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 25
Testing effectiveness (Phase 2)Study completedNCT04251949
What this trial is testing

Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.

Who this might be right for
Oral CancerOropharyngeal Cancer
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05197426
What this trial is testing

Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Bristol-Myers Squibb 19
Testing effectiveness (Phase 2)Study completedNCT01385748
What this trial is testing

Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Who this might be right for
Oral Mucositis
Valerio Therapeutics 183
Early research (Phase 1)Looking for participantsNCT06046495
What this trial is testing

The Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 81
Testing effectiveness (Phase 2)UnknownNCT02285530
What this trial is testing

GDF15 Based TPF Induction Chemotherapy for OSCC Patients

Who this might be right for
Mouth NeoplasmsCarcinoma, Squamous Cell
Shanghai Jiao Tong University School of Medicine 72
Not applicableLooking for participantsNCT05317494
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

Who this might be right for
Acute Myeloid Leukemia
AbbVie 100
Not applicableStudy completedNCT03653039
What this trial is testing

Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy

Who this might be right for
Oral NeoplasmPharynx CancerLarynx Cancer
Michael Seltz Kristensen 48
Early research (Phase 1)Looking for participantsNCT07401381
What this trial is testing

Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

Who this might be right for
Hormone Receptor Positive Early Breast Cancer
Rovi Pharmaceuticals Laboratories 120
Post-approval studies (Phase 4)Study completedNCT01328054
What this trial is testing

A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval

Who this might be right for
Cancer
GlaxoSmithKline 58
Next Page